Clin Colon Rectal Surg 2009; 22(3): 156-160
DOI: 10.1055/s-0029-1236159
© Thieme Medical Publishers

The Medical and Nonoperative Treatment of Diverticulitis

Heath Beckham1 , Charles B. Whitlow1
  • 1Department of Colon and Rectal Surgery, Ochsner Clinic Foundation, New Orleans, Louisiana
Further Information

Publication History

Publication Date:
10 August 2009 (online)

ABSTRACT

The success of medical management for diverticular disease depends on the patient's presentation and degree of response to treatment. The patient's presentation can be grouped into categories using classification systems such as the modified Hinchey system. Clinical presentation and diagnostic studies help to group patients. Mild disease can often be managed with oral antibiotics as an outpatient; more severe disease requires hospitalization, bowel rest, and intravenous antibiotics. Interventions such as percutaneous drainage of associated abscesses may allow successful medical management. Probiotics and antiinflammatories may have a supportive role. Indications for elective resections are discussed.

REFERENCES

  • 1 Jacobs D O. Clinical practice. Diverticulitis.  N Engl J Med. 2007;  357(20) 2057-2066
  • 2 Kircher M, Rhea J, Kihiczak D, Novelline R. Frequency, sensitivity, and specificity of individual signs of diverticulitis on thin-section helical CT with colonic contrast material.  Am J Roentgenol. 2002;  178 1313-1318
  • 3 Rafferty J, Shellito P, Hyman N H, Buie W D. Standards Committee of American Society of Colon and Rectal Surgeons . Practice parameters for sigmoid diverticulitis.  Dis Colon Rectum. 2006;  49(7) 939-944
  • 4 Hinchey E J, Schaal P G, Richards G K. Treatment of perforated diverticular disease of the colon.  Adv Surg. 1978;  12 85-109
  • 5 Kaiser A M, Jiang J-K, Lake J P et al.. The management of complicated diverticulitis and the role of computed tomography.  Am J Gastroenterol. 2005;  100(4) 910-917
  • 6 Mizuki A, Nagata H, Tatemichi M et al.. The out-patient management of patients with acute mild-to-moderate colonic diverticulitis.  Aliment Pharmacol Ther. 2005;  21(7) 889-897
  • 7 Hjern F, Josephson T, Altman D et al.. Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory?.  Scand J Gastroenterol. 2007;  42(1) 41-47
  • 8 Rao P, Rhea J, Novelline R et al.. Helical CT with only colonic contrast material for diagnosing diverticulitis: prospective evaluation of 150 patients.  Am J Roentgenol. 1998;  170 1445-1449
  • 9 Werner A, Diehl S J, Farag-Soliman M, Düber C. Multi-slice spiral CT in routine diagnosis of suspected acute left-sided colonic diverticulitis: a prospective study of 120 patients.  Eur Radiol. 2003;  13(12) 2596-2603
  • 10 Ambrosetti P, Becker C, Terrier F. Colonic diverticulitis: impact of imaging on surgical management–a prospective study of 542 patients.  Eur Radiol. 2002;  12(5) 1114-1119
  • 11 Ambrosetti P, Chautems R, Soravia C, Peiris-Waser N, Terrier F. Long-term outcome of mesocolic and pelvic diverticular abscesses of the left colon: a prospective study of 73 cases.  Dis Colon Rectum. 2005;  48(4) 787-791
  • 12 Siewart B, Tye G, Kruskal J, Sosna J, Opelka F. Impact of CT-guided drainage in the treatment of diverticular abscesses: size matters.  Am J Roentgenol. 2006;  186 680-686
  • 13 Small A J, Young-Fadok T M, Baron T H. Expandable metal stent placement for benign colorectal obstruction: outcomes for 23 cases.  Surg Endosc. 2008;  22(2) 454-462
  • 14 Forshaw M J, Sankararajah D, Stewart M, Parker M C. Self-expanding metallic stents in the treatment of benign colorectal disease: indications and outcomes.  Colorectal Dis. 2006;  8(2) 102-111
  • 15 Paúl L, Pinto I, Gómez H, Fernández-Lobato R, Moyano E. Metallic stents in the treatment of benign diseases of the colon: preliminary experience in 10 cases.  Radiology. 2002;  223(3) 715-722
  • 16 Dobbins C, Defontgalland D, Duthie G, Wattchow D A. The relationship of obesity to the complications of diverticular disease.  Colorectal Dis. 2006;  8(1) 37-40
  • 17 Stollman N H, Raskin J B. Diverticular disease of the colon.  J Clin Gastroenterol. 1999;  29(3) 241-252
  • 18 Painter N S, Burkitt D P. Diverticular disease of the colon: a deficiency disease of Western civilization.  BM J. 1971;  2(5759) 450-454
  • 19 Brodribb A J, Humphreys D M. Diverticular disease: three studies. Part II: Treatment with bran.  BMJ. 1976;  1(6007) 425-428
  • 20 Hyland J M, Taylor I. Does a high fibre diet prevent the complications of diverticular disease?.  Br J Surg. 1980;  67(2) 77-79
  • 21 Taylor I, Duthie H L. Bran tablets and diverticular disease.  BMJ. 1976;  1(6016) 988-990
  • 22 Brodribb A J. Treatment of symptomatic diverticular disease with a high-fibre diet.  Lancet. 1977;  1(8013) 664-666
  • 23 Smits B J, Whitehead A M, Prescott P. Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet.  Br J Clin Pract. 1990;  44(8) 314-318
  • 24 Hodgson W J. The placebo effect. Is it important in diverticular disease?.  Am J Gastroenterol. 1977;  67(2) 157-162
  • 25 Ornstein M H, Littlewood E R, Baird I M, Fowler J, North W R, Cox A G. Are fibre supplements really necessary in diverticular disease of the colon? A controlled clinical trial.  Br Med J (Clin Res Ed). 1981;  282(6273) 1353-1356
  • 26 Strate L L, Liu Y L, Syngal S, Aldoori W H, Giovannucci E L. Nut, corn, and popcorn consumption and the incidence of diverticular disease.  JAMA. 2008;  300(8) 907-914
  • 27 White J A. Probiotics and their use in diverticulitis.  J Clin Gastroenterol. 2006;  40(Suppl 3) S160-S162
  • 28 Frič P, Zavoral M. The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon.  Eur J Gastroenterol Hepatol. 2003;  15(3) 313-315
  • 29 Tursi A, Brandimarte G, Elisei W et al.. Mesalamine and/or Lactobacillus casei for maintaining remission of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized study.  Dig Liver Dis. 2005;  37 S20
  • 30 Papi C, Ciaco A, Koch M, Capurso L. Diverticular Disease Study Group . Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial.  Ital J Gastroenterol. 1992;  24(8) 452-456
  • 31 Papi C, Ciaco A, Koch M, Capurso L. Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial.  Aliment Pharmacol Ther. 1995;  9(1) 33-39
  • 32 Latella G, Pimpo M T, Sottili S et al.. Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon.  Int J Colorectal Dis. 2003;  18(1) 55-62
  • 33 D'Incà R, Pomerri F, Vettorato M G et al.. Interaction between rifaximin and dietary fibre in patients with diverticular disease.  Aliment Pharmacol Ther. 2007;  25(7) 771-779
  • 34 Colecchia A, Vestito A, Pasqui F et al.. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease.  World J Gastroenterol. 2007;  13(2) 264-269
  • 35 Di Mario F, Aragona G, Leandro G et al.. Efficacy of mesalazine in the treatment of symptomatic diverticular disease.  Dig Dis Sci. 2005;  50(3) 581-586
  • 36 Comparato G, Fanigliulo L, Aragona G et al.. Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment?.  Dig Dis. 2007;  25 252-259
  • 37 Tursi A, Brandimarte G, Giorgetti G M, Elisei W. Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon.  Dig Dis Sci. 2007;  52(3) 671-674
  • 38 Tursi A, Brandimarte G, Daffinà R. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.  Dig Liver Dis. 2002;  34(7) 510-515
  • 39 Brandimarte G, Tursi A. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.  Med Sci Monit. 2004;  10(5) PI70-PI73
  • 40 Salem L, Veenstra D L, Sullivan S D, Flum D R. The timing of elective colectomy in diverticulitis: a decision analysis.  J Am Coll Surg. 2004;  199(6) 904-912
  • 41 Richards R J, Hammitt J K. Timing of prophylactic surgery in prevention of diverticulitis recurrence: a cost-effectiveness analysis.  Dig Dis Sci. 2002;  47(9) 1903-1908
  • 42 Chapman J, Davies M, Wolff B et al.. Complicated diverticulitis: is it time to rethink the rules?.  Ann Surg. 2005;  242(4) 576-581 discussion 581-583
  • 43 Chapman J R, Dozois E J, Wolff B G, Gullerud R E, Larson D R. Diverticulitis: a progressive disease? Do multiple recurrences predict less favorable outcomes?.  Ann Surg. 2006;  243(6) 876-830 discussion 880-883
  • 44 Kaiser A M. Complicated diverticulitis: it is not yet time to rethink the rules!.  Ann Surg. 2006;  243(5) 707-708, author reply 708–709
  • 45 Novitsky Y, Sechrist C, Payton B, Kercher K, Heniford B. Do the risks of emergent colectomy justify nonoperative management strategies for recurrent diverticulitis?.  Am J Surg. 2009;  187(2) 227-231

Charles B WhitlowM.D. 

Department of Colon and Rectal Surgery, Ochsner Clinic Foundation

1514 Jefferson Hwy., New Orleans, LA 70121

Email: cwhitlow@ochsner.org